$4.24
-0.23-5.15%
At close: -
$4.55
0.317.31%
After Hours: Nov 22, 7:54 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Telomir Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.